COX-2 in liver,from regeneration to hepatocarcinogenesis:What we have learned from animal models?

被引:12
|
作者
Paloma Martín-Sanz [1 ,2 ]
Rafael Mayoral [1 ,2 ]
Marta Casado [1 ,3 ]
Lisardo Boscá [1 ,2 ]
机构
[1] Biomedical Network Center for the Study of Hepatic and Digestive Diseases(CIBERehd)
[2] Department of Metabolism and Cell Signaling,Institute of Biomedical Research "Alberto Sols"(CSIC-UAM)
[3] Department of Pathology and Molecular and Cellular Therapy,Institute of Biomedicine of Valencia(IBV-CSIC)
关键词
Cyclooxygenase; 2; Prostaglandins; Liver diseases; Apoptosis; Inflammation; Animal models;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
The use of animals lacking genes or expressing genes under the control of cell-specific promoters has signifi cantly increased our knowledge of the genetic and molecular basis of physiopathology,allowing testing of functional hypotheses and validation of biochemical and pharmacologic approaches in order to understand cell function.However,with unexpected frequency,gene knockout animals and,more commonly,animal models of transgenesis give experimental support to even opposite conclusions on gene function.Here we summarize what we learned on the role of cyclooxygenase 2(COX-2) in liver and revise the results obtained in 3 independent models of mice expressing a COX-2 transgene specifi cally in the hepatocyte.Upon challenge with pro-inflammatory stimuli,the animals behave very differently,some transgenic models having a protective effect but others enhancing the injury.In addition,one transgene exerts differential effects on normal liver physiology depending on the transgenic animal model used.
引用
收藏
页码:1430 / 1435
页数:6
相关论文
共 50 条
  • [1] COX-2 in liver, from regeneration to hepatocarcinogenesis: What we have learned from animal models?
    Martin-Sanz, Paloma
    Mayoral, Rafael
    Casado, Marta
    Bosca, Lisardo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (12) : 1430 - 1435
  • [2] Cardiovascular imaging: what have we learned from animal models?
    Santos, Arnoldo
    Fernandez-Friera, Leticia
    Villalba, Maria
    Lopez-Melgar, Beatriz
    Espana, Samuel
    Mateo, Jesus
    Mota, Ruben A.
    Jimenez-Borreguero, Jesus
    Ruiz-Cabello, Jesus
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [3] Hyperoxia and Lungs: What We Have Learned From Animal Models
    Amarelle, Luciano
    Quintela, Lucia
    Hurtado, Javier
    Malacrida, Leonel
    FRONTIERS IN MEDICINE, 2021, 8
  • [4] What have we learned from animal models of idiosyncratic, drug-induced liver injury?
    Roth, Robert A.
    Ganey, Patricia E.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (06) : 475 - 491
  • [5] Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models?
    Renard, C
    Van Obberghen, E
    DIABETES & METABOLISM, 2006, 32 (01) : 15 - 29
  • [6] Prevention of hemolytic disease of the fetus and newborn: what have we learned from animal models?
    Cruz-Leal, Yoelys
    Marjoram, Danielle
    Lazarus, Alan H.
    CURRENT OPINION IN HEMATOLOGY, 2017, 24 (06) : 536 - 543
  • [7] New targets for treatment of diabetic nephropathy: what we have learned from animal models
    Brosius, Frank C., III
    Alpers, Charles E.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2013, 22 (01) : 17 - 25
  • [8] Therapeutic strategies in Parkinson's disease: what we have learned from animal models
    Valadas, Jorge S.
    Vos, Melissa
    Verstreken, Patrik
    YEAR IN NEUROLOGY AND PSYCHIATRY, 2015, 1338 : 16 - 37
  • [9] The Pathophysiology of Sleep Apnoea: What We have Learned from Animal Models of Chronic Intermittent Hypoxia
    O'Halloran, Ken D.
    Bradford, Aidan
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2007, 3 (01) : 19 - 27
  • [10] A "Furry-Tale' of Zika Virus Infection: What Have We Learned from Animal Models?
    Nazerai, Loulieta
    Christensen, Jan Pravsgaard
    Thomsen, Allan Randrup
    VIRUSES-BASEL, 2019, 11 (01):